M b s t r a c t OBJECTIVE SUBJECTS AND METHODS
Introduction
Whether liver surgery is indicated for benign liver lesions remains controversial [1] particularly in hepatocellular adenoma (HCA) and focal nodular hyperplasia (FNH). Both tumours are typically seen in middle-aged women and are often incidental findings on abdominal imaging studies [2] . Because of the risk for bleeding and malignant transformation, it is generally accepted that HCAs measuring >5 cm in size should be resected [3] [4] [5] [6] . These risks do not apply in FNH and surgery is therefore not indicated for FNH [7, 8] . However, patients may present with severe abdominal complaints in the presence of a relatively small lesion or a lesion typical of FNH on imaging, without other underlying causes for discomfort. The issue of whether these complaints are correlated with the lesion and outweigh the possible risks of intervention in such patients creates a dilemma.
The diagnostic workup of HCA and FNH is based mainly on crosssectional imaging studies, of which magnetic resonance imaging (MRI) and computed tomography (CT) are commonly used to characterize lesions. The most sensitive method of differentiating HCA and FNH is MRI with hepatobiliary contrast (Primovist® or MultiHance®) [9] [10] [11] . If imaging modalities are inconclusive, a liver biopsy may be necessary to achieve a final diagnosis [12] . When a patient is considered for surgery, he or she should be well informed and should ideally be included in a shared decision-making process. Subjective symptoms and impact on daily life are just as important as the statistics of surgical risks. Given these dilemmas in clinical decision making, the present study was conducted to assess the outcomes of surgical intervention in terms of complications and the relief of symptoms in patients presenting with lesions compatible with HCA or FNH.
Between January 2008 and September 2011, all consecutive patients with suspected FNH or HCA of >2 cm based on imaging studies were enrolled in this prospective study (follow-up ended in September 2012). The local medical ethics committee approved the study protocol and written informed consent was obtained from all included patients. Exclusion criteria were suspected (metastatic) malignant disease and the presence of risk factors for malignant liver lesions, including chronic hepatitis, cirrhosis, elevated a-fetoprotein (a-FP) or carcinoembryonic antigen (CEA) in blood serum, and pregnancy. 
Figure 1
Patients underwent MRI of the liver with Gd-EOB-DTPA (gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid; Primovist ®) using a 1.5-T MRI scanner (Avanto; Siemens Healthcare AG, Munich, Germany). The dynamic contrast-enhanced T1-weighted volumetric interpolated breath-hold examination (VIBE) sequences were made at 30 s (arterial), 60 s (venous), 90 s and 180 s (late) after i.v. bolus injection of 0.025 mmol/kg gadoxetate disodium. Axial and coronal hepatobiliary phase images were made at 20 min after injection using single breath-hold sequences. The diagnosis of HCA was based on arterial enhancement, with possible washout during the portal phase, the presence of bleeding, fat or glycogen, and the absence of a central scar. The diagnosis of FNH was based on the presence of a central scar, arterial enhancement and the absence of signs of washout during the portal phase of imaging. Finally, the lesions were evaluated for signal intensity compared with surrounding liver tissue on the T1-weighted hepatobiliary series at 20 min after injection. An isointense or hyperintense signal status of the lesion was regarded as diagnostic for FNH, and hypointensity was considered diagnostic for HCA. Any MRI scans of lesions without these characteristics were regarded as inconclusive. The largest lesion in each patient was evaluated. Until the MRI with Primovist® was proven sensitive for differentiating HCA from FNH [11] a core biopsy of the lesion and normal surrounding liver parenchyma was standard in this study (using a 16-gauge needle, two lesional biopsies and one or two normal liver tissue samples). The morphological characteristics of HCA include hepatocellular proliferation without cytonuclear atypia, with solitary arteries and the absence of portal tracts. A well-developed reticulin framework is seen, without pseudoglandular growth patterns. In addition to standard liver stainings, including haematoxylin and eosin, collagen and CK7, additional immunohistochemical staining was performed to classify molecular subtypes of HCA [13] . Morphological characteristics of FNH include fibrotic strands, no nuclear atypia, and typical map-like glutamine synthetase (GS) expression on immunohistochemical staining. Halfway through 2011, the policy of standard biopsy was changed to one of biopsy only in the event of inconclusive MRI findings in lesions of >5 cm with or without symptoms.
Symptoms at the time of presentation (baseline) were assessed using a questionnaire; this was readministered at 6 months from baseline or the intervention (second evaluation). The questionnaire was based on the validated McGill Pain Questionnaire [14] and its Dutch translation [15] and included a visual analogue scale (VAS) with which to assess pain and discomfort, the number of words count (NWC; S, sensory; A, affective; E, evaluation; NWC total), and a pain rating index (PRI; S, sensory; A, affective; E, evaluation; PRI total).
Selective transarterial embolization (TAE) represented the treatment of choice in patients presenting with haemodynamic instability caused by tumoral bleeding. Surgical treatment of HCA was undertaken if the lesion was >5 cm. Smaller lesions were only resected if the patient presented with persisting complaints which could not be explained by other underlying causes including gallbladder, gastric, bowel, kidney or gynaecological conditions. Depending on the patient's history and the physical examination and imaging findings already available, patients underwent additional endoscopy and/or colonoscopy, and abdominal imaging if the standard workup for the liver did not cover other plausible causes of discomfort. Focal nodular hyperplasia was only resected if symptoms were severe (VAS scores of _ 7 for >6 months, with the patient describing the complaint as 'unbearable' and 'restrictive' in daily life) and other possible causes of discomfort had been investigated and excluded. Liver resections were classified as major, defined as the resection of three or more Couinaud's segments, or minor; defined as the resection of fewer than three liver segments, including enucleation and (sub) segmental resections. Surgery was performed using standard techniques. All major resections were performed in an open procedure, whereas minor resections were performed in open surgery or laparoscopically depending on the tumor's location. Tumour characteristics, type of liver resection, postoperative morbidity (Dindo-Clavien class [16] ) and mortality were recorded.
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Statistical analysis A total of 120 patients with suspected HCA or FNH were initially enrolled. Nine patients (8%) were given other diagnoses after an initial diagnostic workup with MRI (haemangioma, n = 4, 3%; hepatocellular carcinoma, n = 2, 2%; hamartoma, n = 2, 2%; angiomyolipoma, n = 1, <1%). One patient with HCA (<1%) withdrew during the diagnostic workup (Fig. 1) . The remaining 110 patients were included in the study (Table 1). Diagnosis was based on histopathological examination in 44 (86%) of the 51 patients with HCA (34/44 resection specimens; 10/44 biopsies) and 39 (66%) of the 59 patients with FNH (16/39 resection specimens; 24/39 biopsies). Because of sampling errors, biopsy materials of four (8%) HCA and four (7%) FNH lesions were not sufficient for diagnosis and diagnosis was therefore based on MRI findings. The subclassification of HCA was undertaken in 10 biopsy and 34 resection specimens. Six samples appeared insufficient for additional immunohistochemical staining. Results in the remaining 38 lesion samples showed inflammatory HCA in 20 lesions, steatotic HCA in eight lesions, and unclassified HCA in 10 lesions. No lesions were identified as being of the b-catenin subtype. In three (6%) patients with HCA and 14 (24%) with FNH, no histopathology was obtained and diagnosis was based on MRI findings alone.
Results
A total of 105 patients underwent MRI of the liver; this showed HCA in 45 (43%) patients (one of these 45 patients was misdiagnosed; histopathology revealed FNH) and FNH in 60 (57%) patients. Two lesions showed discrepancies between the hepatobiliary phase and dynamic series; the diagnosis of HCA was inconclusive and corroborated by histopathology in these patients. In one patient, MRI was inconclusive as a result of motion artefacts and the diagnosis of HCA was based on histopathology. No MRI was performed in four patients; two of these patients were claustrophobic and were diagnosed according to histopathology, and two underwent CT imaging. Hepatic steatosis was seen in 29 (57%) of the 51 patients with HCA and in 12 (20%) of the 59 patients with FNH (P = 0.024).
Results of treatment are summarized in Table 2 . Conservative treatment was delivered in 61 (55%) patients, including 18 (35%) patients with HCA and 43 (73%) with FNH (P <0.001). Eight (16%) paStatistical analysis was performed using IBM spss Statistics for Windows Version 20 (IBM Corp., Armonk, NY, USA). Descriptive statistics were used for the study population. The Mann-Whitney U-test for medians was used to analyse continuous data. Pearson's chi-squared, Fisher's exact and Spearman correlation tests were used for categorical data analyses, including gamma and Somers' D measures for ordinal by ordinal analyses.17 Statistical tests were evaluated at the 5% level of significance.
Imaging Characteristics
Treatment tients with HCA presented at the emergency room with acute pain caused by bleeding of the lesion; these eight patients were admitted, stabilized and subjected to selective TAE. One of these eight patients underwent laparotomy within days of TAE because of abdominal compartment syndrome and four underwent elective resection of the lesion(s). Resection was performed in 33 (65%) patients with HCA and in 16 (27%) patients with FNH. Significantlymore resections were performed for HCA than for FNH (P < 0.001). Complications after surgery occurred in both groups and affected 11 of the 33 patients with HCA and seven of the 16 patients with FNH (P = 0.344). Grade I and II complications were most common and were seen in 14 of the 18 patients with complications.
In total, 34 of the 49 patients who underwent resection reported abdominal complaints prior to surgery. Symptoms were relieved in 30 of these 34 patients after surgery (Table 3) . Symptoms are summarized in Tables 3 and 4 . The pain questionnaire was completed by 48 (94%) of the 51 patients with HCA. Pain categories present in at least one third of the patients with HCA and FNH are shown in Table 4 . Specific to HCA rather than to FNH was 'drilling' (P = 0.045). Specific pain categories reported by the eight patients who submitted to emergency TAE but not by HCA patients who did not undergo emergency TAE included 'shooting' (P = 0.044), 'lacerating' (P = 0.032), 'crushing' (P = 0.034), 'splitting (P = 0.001) and 'wrenching' (P = 0.023) pain. The NWC was higher in the emergency TAE patient group than in the entire HCA patient group (Sensory: P = 0.009; Affective: P = 0.026; Evaluation: P = 0.005; Total: P = 0.011), as was the PRI (Sensory: P = 0.001; Affective: P = 0.036; Evaluation: P = 0.033; Total: P = 0.015). No differences in the NWC and PRI were found between patients with HCA or FNH when corrected for patients who underwent emergency TAE (P = 0.775). Table 3 Figure 3
Discussion
This prospective study of outcomes of treatment of HCA and FNH shows that resection of the lesion(s) is safe and results in the relief of complaints in the majority of symptomatic patients with HCA or FNH. No mortality occurred and most postoperative complications were minor according to the Clavien-Dindo classification (Grade I or II). These findings are in accordance with a previous publication from the present authors' institution, showing that liver resection for benign hepatobiliary lesions was not associated with mortality and resulted in less morbidity than it did in patients undergoing resection for malignancies [18] .
Because HCA and FNH are benign tumours, limited resections usually suffice to remove all tumour tissue.Most of these tumours are amenable to parenchymasparing techniques. For example, lesions located in segment I allow the isolated resection of segment I, as was performed in three patients in the present series [19] . Of note are the blood transfusions required for minor resections in this series (two patients). Both HCA and FNH are hypervascular tumours and thus, in dissection, many blood vessels that traverse the interface between tumour and surrounding liver parenchyma are encountered. Enucleation of the tumour, therefore, may result in considerable blood loss. In the authors' experience, the use of the Cavitron® Ultrasonic Surgical Aspirator (CUSA®), in combination with a Pringle manoeuvre, enables the surgeon to follow the plane between the tumour and adjacent parenchyma and to manage the blood vessels selectively. In addition, non-anatomical resections may result in longer dissection times and larger wound surfaces, both of which contribute to greater blood loss during the procedure.
Although both HCA and FNH are benign hepatic lesions, associated findings are quite different, as this study shows. Patients with HCA more often had elevated serum liver function tests (72%), hepatic steatosis (57%) and multiple lesions. Eight of the patients with HCA presented at the emergency room with acute pain caused by the bleeding of the lesion, whereas none of the patients with FNH needed emergency care. Significantly more resections were performed in HCA than in FNH patients. Without intervention, patients with HCA showed symptom relief over time. The differences between the groups may in part be explained by the occurrence of bleeding in HCA: some bleeding in HCA will need emergency intervention, and part of the discomfort caused by bleeding HCA will subside over time as the haematoma is absorbed.
This study showed not only differences between the types of hepatic lesion, but also similarities. Resection of HCA and FNH resulted in the relief of symptoms in both groups. These results are in line with those reported by Perrakis et al., who noted relief in 95% of symptomatic patients with HCA [3] . Patients with lesions in the left lateral segments that give rise to abdominal complaints and additional gastric complaints benefit particularly from surgery, which can Table 4 achieve complete symptom relief. Gastric complaints could not be explained by any causes other than the lesion in the left liver. However, in the present study, size was not correlated with symptoms. This probably reflects some degree of selection bias as patients with abdominal complaints will seek medical attention and those without will present only if the lesion is found incidentally. The high rate of resections for FNH is also explained by this selection bias as patients with severe complaints will seek medical assistance and will be more persistent in their wish for (even invasive) treatment. Complications in FNH are rare and are cited only in case reports [20] . Assessing the severity of symptoms and whether these originate from the detected liver lesion remains difficult. Abdominal pain or discomfort can have a number of other causes, which should be ruled out before surgery is planned. When feasible, a laparoscopic resection is preferred over an open procedure, especially for lesions in the left or anterior liver segments. It is well documented that the postoperative LoS is shorter after laparoscopic surgery and, particularly in this young and mainly female group of patients, the cosmetic result plays an important role [21] . However, the feasibility of a laparoscopic approach should not influence perceptions of indications for resection.
Few treatment options other than surgical intervention have been proposed. Percutaneous radiofrequency ablation (RFA) has been performed for HCA and FNH with good results and cost efficiency ratios [22, 23] . However, the procedure is limited by the location and size of the tumour. It is possible that residual tumour tissue is less problematic in a benign tumour. In the treatment of lesions of < 3 cm, RFA is a good treatment option and, depending on the location of the lesion, may even be selected as the treatment of choice. Further research should determine the long-term outcomes and limitations of RFA in the ablation of HCA and FNH. At the present authors' institution, TAE is considered the first line treatment modality when a patient presents with massive bleeding and rupture of a hepatic tumour, including HCA [24, 25] . Through the close collaboration of a skilled interventional radiologist and surgeon, laparotomy can be avoided in these emergencies. The technique can also be used as a minimally invasive, preventive intervention that hypothetically decreases the risk for future bleeding; it was applied in this study in an HCA patient who was a Jehovah's Witness. As yet, no data are available on tumour behaviour after TAE, including the risk for malignant transformation of the remaining adenomatous tissue.
Based on the findings of the present study and the available literature, the present authors propose the following approach should be taken in patients with HCA and FNH. Diagnostic workup should include hepatobiliary contrast MRI [11] . In patients diagnosed with FNH, resection is advised only if abdominal complaints are severe and other causes of symptoms have been excluded. All patients with HCA should discontinue oral contraceptives. Until risk analyses during pregnancy have been properly studied, all patients should undergo close follow-78 79
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References up during pregnancy [26] . Hepatocellular adenoma in male patients and of >5 cm in female patients should be resected [5] . Liver adenomatosis is an arbitrary diagnosis when more than nine HCA lesions (whatever their size) are found, but in the present authors' practice, it is not an indication for liver transplantation. Patients are treated according to the sizes of lesions and the presence of bleeding and symptoms, like any other patient with HCA. In addition, HCA lesions of <5 cm in size, and FNH lesions, if severely symptomatic, can be considered for resection after other possible causes of abdominal complaints have been evaluated. Future studies should determine whether different subtypes of HCA carry different profiles of risk for bleeding, recurrence (however small the risk) and malignant transformation. Subtype classification, however, requires the obtaining of biopsy material of the lesion, which is subject to sampling errors. Improvements in MRI techniques may play a role in the noninvasive assessment of these subtypes and facilitate the more accurate selection of patients who will benefit from surgery.
In conclusion, if patients with HCA and FNH require surgery, limited resection can be carried out with low morbidity and without mortality. Patients with preoperative symptoms show a high rate of postoperative symptom relief.
